Search results
Results from the WOW.Com Content Network
Levetiracetam, sold under the brand name Keppra among others, is a novel antiepileptic drug [7] used to treat epilepsy. [8] It is used for partial-onset, myoclonic, or tonic–clonic seizures, [7] and is taken either by mouth as an immediate or extended release formulation or by injection into a vein.
The ketogenic diet consists of a high-fat, low-carbohydrate diet, and has shown good results in patients whose epilepsy has not responded to medications and who cannot receive surgery. The vagus nerve stimulator is a device that can be implanted into patients with epilepsy, especially that which originates from a specific part of the brain ...
Lamotrigine can induce a type of seizure known as a myoclonic jerk, which tends to happen soon after the use of the medication. [69] When used in the treatment of myoclonic epilepsies such as juvenile myoclonic epilepsy, lower doses (and lower plasma levels) are usually needed, as even moderate doses of this drug can induce seizures, including ...
It has been found to be more effective than clonazepam in the treatment of West syndrome, which is an age-dependent epilepsy, affecting the very young. In uncontrolled studies, nitrazepam has shown effectiveness in infantile spasms and is sometimes considered when other anti-seizure drugs have failed. [ 9 ]
Carbamazepine, sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain. [ 4 ] [ 1 ] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder .
The prevalence of seizure clusters is uncertain given that studies have used different definitions to define them. [41] However, estimates suggest that the prevalence may range from 5% to 50% of people with epilepsy. [42] People with refractory epilepsy who have a high seizure frequency are at the greatest risk for having seizure clusters.
While weight loss and type 2 diabetes drugs can truly be life-changing for many people, Dr. Landsverk points out that these drugs are expensive and some people experience adverse side effects.
SUDEP is the number one cause of epilepsy-related death in people with pharmacoresistant epilepsy. [20] Children with epilepsy have a cumulative risk of dying suddenly of 7% within 40 years. [20] Within the pediatric population, SUDEP accounts for 30-50% of the deaths in severe early onset epilepsies, affecting between 1 in 500 and 1 in 1000 ...